TAU makes breakthrough in drug delivery to treat inflammatory bowel disease
To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and ...
So *That's* Why You Get More Lactose Intolerant As You Get Older
Other things that could cause an increase in lactose intolerance include infections, inflammatory or autoimmune diseases like ...
Stoma-changing facilities added to railway toilets
The changes apply to toilets at Cleethorpes, Dewsbury, Grimsby, Huddersfield, Hull, Malton, Manchester Airport, Northallerton ...
Crohn’s disease doesn’t slow down Hutchinson girls soccer captain
Kendall Markovic was a leader on and off the field when Hutchinson’s girls and boys soccer teams played host to Rockford Tuesday. The senior co-captain started as a mid-fielder, plus helped ...
MedPage Today2d
Exclusion Diet in Pediatric Crohn's Tied to Clinical Remission in Small Study
SAN FRANCISCO -- The pediatric Crohn's disease exclusion diet was associated with clinical remission for children with good ...
Lilly reports positive results for Omvoh in Crohn's disease
Eli Lilly (NYSE:LLY) reported positive results from an open-label study of its drug Omvoh in the treatment of moderately to severely active Crohn's disease. The study, called VIVID-2, showed that the ...
BioSpace2d
Equillium’s Itolizumab Goes Toe-to-Toe With Humira in Ulcerative Colitis
In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...
Eli Lilly's Recently Approved Inflammatory Bowel Disease Drug Shows Sustained And Durable Treatment At Two Years
Eli Lilly And Cao (NYSE:LLY) announced the results from the VIVID-2 open-label extension study of Omvoh (mirikizumab-mrkz).
Eli Lilly reports sustained Crohn's disease treatment success
INDIANAPOLIS - Eli Lilly and Company (NYSE: NYSE:LLY), a pharmaceutical giant with a market capitalization of $783.7 billion ...
Everyday Health2d
Ulcerative Colitis Diet: What to Eat and Avoid, 7-Day Meal Plan, More
Low-fiber fruits and vegetables, lean proteins, and foods rich in omega-3 fatty acids tend to be easier on an inflamed gut, ...
2minutemedicine.com2d
Mirikizumab is safe and effective in patients with moderate-to-severe Crohn’s disease
The composite of patient-reported clinical response and endoscopic response was significantly greater in mirikizumab versus ...
The American Journal of Managed Care3d
Mirikizumab Demonstrates Superior Maintenance Efficacy in UC Treatment
Mirikizumab showed superior maintenance efficacy over most treatments for ulcerative colitis (UC), according to a network ...